DMI-Logo
search-iconsearch-icon

Oncology Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Oncology
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 October 08
Polycythemia Vera Market Size, Share, Trends and Forecast 2026-2035
Polycythemia vera market reached US$1.94 billion in 2025 and is projected to reach US$3.89 billion by 2035, driven by interferons, JAK inhibitors and emerging hepcidin therapies.
Starting from
$4350$2999
Published: 2026 October 08
FGFR Inhibitor Market Size, Share, Trends and Forecast 2026-2035
FGFR inhibitor market reached US$1.62 billion in 2025 and is projected to reach US$7.04 billion by 2035, driven by genomic testing and selective targeted therapies.
Starting from
$4350$2999
Published: 2026 October 05
Oral SERD Market Size, Share, Trends and Forecast 2026-2035
Oral SERD market reached US$754.2 million in 2025 and is projected to reach US$3.20 billion by 2035, growing at a 15.6% CAGR during 2026–2035.
Starting from
$4350$2999
Published: 2026 September 30
DDR Defective Tumors Market Size, Share, Industry, Forecast and Outlook (2026-2033)
Global DDR Defective Tumors Market size reached US$ 9.16 billion in 2025 and is expected to reach US$ 14.7 billion by 2033, growing at a CAGR of 7.0%
Starting from
$4350$2999
Published: 2026 September 29
Oncology Biosimilars Market Size, Share, Trends, and Forecast (2026-2035)
The Oncology Biosimilars Market is projected to grow from US$ 8.02 billion in 2026 to US$ 50.02 billion by 2035 at a CAGR of 18.6%.
Starting from
$4350$2999
Published: 2026 September 29
Hemangioma Treatment Market Size, Share, Industry, Forecast and outlook 2026-2033
Hemangioma Treatment Market reached USD 318.3 million in 2025 and is expected to reach USD 427.9 million by 2033
Starting from
$4350$2999
Published: 2026 September 26
Gall Bladder Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2026-2033)
The Global Gall Bladder Cancer Treatment Market reached USD 93.2 million in 2025, growing at a CAGR of 5.5% during the forecast period 2026-2033.
Starting from
$4350$2999
Published: 2026 September 15
Malignant Mesothelioma Therapeutics Market Size, Share, Industry, Forecast and outlook (2026-2033)
The Global Malignant Mesothelioma Therapeutics Market is projected to reach at a CAGR of 8.5% during the forecast period (2026-2033).
Starting from
$4350$2999
Published: 2026 September 09
Epithelioid Sarcoma Treatment Market Size, Share, Industry, Forecast and outlook (2026-2033)
Global Epithelioid Sarcoma Treatment Market reached US$ 1.58 billion in 2025, growing with a CAGR of 9.1% during the forecast period 2026-2033.
Starting from
$4350$2999
Published: 2026 September 01
Pleuropulmonary Blastoma Treatment Market 2033: Global Size, Growth Trends & Diagnostic Advances
The global pleuropulmonary blastoma treatment market size reached US$ 649.44 Million in 2025 and is expected to reach US$ 995.33 Million by 2033
Starting from
$4350$2999